Revised SPC: Efexor (venlafaxine) XL150 mg hard prolonged release capsules

SPC notes suicide/suicidal thoughts and aggression have been reported during changes in dose and, during discontinuation therefore patients should be closely monitored. Risk of withdrawal symptoms may be dependent on duration and dose of therapy and rate of dose reduction.

Source:

electronic Medicines compendium